 |
|
Chemodectomas of the Middle EarA Comparison of Therapeutic Modalities
George R. Moore, MD;
Jeffrey P. Robbins, MD;
Daniel L. Seale, MD;
G. Slaughter Fitz-Hugh, MD;
William C. Constable, MB, ChB, DMRT
Arch Otolaryngol. 1973;98(5):330-335.
Abstract
Thirty-three cases of chemodectoma are presented, with patients staged in three groups: tympanic (1), tympanomastoid (2), and petrosal-extrapetrosal (3). Surgery is effective in group 1 cases.
Surgery and moderate-dose postoperative cobalt irradiation (3,500 to 4,000 rads in three weeks) are used for more advanced lesions with higher-dose irradiation (5,000 to 5,500 rads in five weeks) reserved for very extensive tumors. Overall control of tumor in these cases is 84% in follow-ups from 1 to 31 years.
Author Affiliations
Charlottesville, Va
From the Department of Otolaryngology and Maxillofacial Surgery (Drs. Moore, Robbins, Fitz-Hugh) and the Division of Radiation Oncology, (Drs. Seale and Constable), University of Virginia Medical School, Charlottesville, Va.
Footnotes
Accepted for publication Oct 10, 1972.
Read before the Section Council of Otolaryngology at the 121st annual convention of the American Medical Association, San Francisco, June 20, 1972.
Reprint requests to Division of Radiation Oncology, University of Virginia Medical School, Charlottesville, VA 22901 (Dr. Constable).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Resident's Page
FECHNER
Arch Otolaryngol Head Neck Surg 1979;105:626-628.
ABSTRACT
Primary Tumors of the External and Middle Ear: II. A Clinicopathologic Study of 14 Paragangliomas and Three Meningiomas
Chen and Dehner
Arch Otolaryngol Head Neck Surg 1978;104:253-259.
ABSTRACT
|
